// App-Quantinova.ai

4785 : Prognostic Value of Complex Karyotype and Monosomal Karyotype in Patients with Adult Acute Lymphoblastic Leukemia Treated with Risk-Adapted Protocols

Researchers

Presenter

  • Josep-Maria Ribera

Principal Investigators

  • Jesus M Hernandez-Rivas

  • MJ Moreno

  • Jose Sarra

  • Eloy Del Potro

  • Pere Barba

  • Teresa Bernal

  • Maria-Luz Amigo

  • Carlos Grande

  • Arancha Bermudez

  • Ramon Gua rdia

  • Isabel Granada

  • Andres Llorente

  • Maria Jesus Penarrubia

  • Jesus Arias

  • Miguel Angel Sanz

  • Evarist Feliu

  • Javier Grau

  • Pau Montesinos

  • Jose Gonzalez-Campos

  • Pascual Fernandez-Abellan

  • Mar Tormo

  • Concha Bethencourt

  • Salut Brunet

Medical Centers

  • Hematology, Hospital Universitario La Fe, Valencia, Spain

  • University Hospital Virgen del Rocio/ CSIC/ Biomedicine Institute of Seville/ University of Seville (Spain), Seville, Spain

  • Clinical Hematology Department, Hospital Universitario Central de Asturias, Asturias, Spain

  • Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol. Josep Carreras Leukemia Research institute, Badalona, Spain

  • Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol. Josep Carreras Leukemia Research institute, Badalona, Spain

  • Clinical Hematology, Hospital U. La Fe, Valencia, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Ph chromosome

Drug/Treatment

  • Imatinib

  • IkT001

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim